Hoeffel, Guillaume http://orcid.org/0000-0002-2534-4972
Debroas, Guilhaume
Roger, Anais http://orcid.org/0000-0003-4872-3171
Rossignol, Rafaelle
Gouilly, Jordi http://orcid.org/0000-0001-8684-7429
Laprie, Caroline
Chasson, Lionel
Barbon, Pierre-Vincent
Balsamo, Anaïs
Reynders, Ana
Moqrich, Aziz
Ugolini, Sophie http://orcid.org/0000-0003-4041-0103
Article History
Received: 6 March 2020
Accepted: 19 April 2021
First Online: 19 May 2021
Competing interests
: Inserm Transfert have filed a provisional international patent application (WO2020/064907) on the clinical use of TAFA4 for treating inflammatory diseases, which lists S.U., G.H., G.D. and A.M. as authors. A.M. is the founder of Tafalgie Thérapeutics, which exploits a patent on the clinical use of TAFA4 (DI 06104-01). All other authors declare no competing interests.